Resources

Type of publications
Regions
Diseases
4872 results found
2021 ∙ Wan Ismail, W. R. Abdul Majid, M. Sh Li, H. Y. Madrim, M. F. Abdul Rahim, S. Sh S. Jeffree, M. S. Azhar, Z. I. Ghazi, H. F. Hassan, M. R.
Safety of dengue vaccine (CYD-TDV) in Asia: a systematic review
South-East Asia Children Adolescents Adults Dengue Efficacy/effectiveness Safety
Rating:
Critically low
2021 ∙ Desalermos, A. Pimienta, M. Kalligeros, M. Shehadeh, F. Diamantopoulos, L. Karamanolis, G. Caldera, F. Farraye, F. A.
Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis
Adults Hepatitis B Influenza Herpes zoster Pneumococcal disease Safety
Rating:
Critically low
2021 ∙ Juvet, L. K. Robertson, A. H. Laake, I. Mjaaland, S. Trogstad, L.
Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
All age groups Influenza Safety
Rating:
Not applicable
2021 ∙ Bandell, A. Ambrose, C. S. Maniaci, J. Wojtczak, H.
Safety of live attenuated influenza vaccine (LAIV) in children and adults with asthma: a systematic literature review and narrative synthesis
Children Adolescents Adults Influenza Safety Efficacy/effectiveness
Rating:
Critically low
2021 ∙ Chen, M. Yuan, Y. Zhou, Y. Deng, Z. Zhao, J. Feng, F. Zou, H. Sun, C.
Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials
Adolescents Adults Older adults COVID-19 Safety Administration
Rating:
Critically low
2021 ∙ Lv, M. Luo, X. Shen, Q. Lei, R. Liu, X. Liu, E. Li, Q. Chen, Y.
Safety, immunogenicity, and efficacy of COVID-19 vaccines in children and adolescents: A systematic review
Children Adolescents COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2021 ∙ Rogliani, P. Chetta, A. Cazzola, M. Calzetta, L.
SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2021 ∙ Sung, K. Y. Chang, T. E. Wang, Y. P. Lin, C. C. Chang, C. Y. Hou, M. C. Lu, C. L.
SARS-CoV-2 vaccination in patients with inflammatory bowel disease: systemic review and meta-analysis
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2021 ∙ Abid, M. A. Abid, M. B.
SARS-CoV-2 vaccine response in CAR T-cell therapy recipients: A systematic review and preliminary observations
All age groups COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2021 ∙ Sakuraba, Atsushi Luna, Alexander Micic, Dejan
Serologic response to coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis
Adults Older adults Healthcare workers COVID-19 Efficacy/effectiveness
Rating:
Critically low
Loading...